Views & Analysis Regulatory consultants: facilitators or obstructors? External regulatory consultants can bring broad experience and expedite approvals.
Events Partner Content 4th Clinical Regulatory Medical Writing Forum The premier medical writing event dedicated to addressi
News UK medicines agency set to lose lucrative EMA work post-Brex... Agency already working on how to share post-Brexit workload.
News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News Report links Sanofi epilepsy drug with thousands of birth de... Depakine and generics linked with defects including spina bifida.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
